Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Terumo is a leading global medical technology company headquartered in Japan. It develops, manufactures, and distributes innovative medical products for healthcare. Key focus areas include cardiovascular therapies, diabetes care, and blood management, aiming to improve patient care worldwide and contribute to quality of life.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Terumo is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Terumo last reported quarterly earnings on 8/7/2026 (Q2 2026). Earnings per share (EPS) came in at 47.74 JPY.
Across its last 3 earnings reports, Terumo stock moved by ±1.4% on average the following day. The largest reaction was -2.9% on 02/13/2026; 1 of 3 reactions were positive.
Terumo has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.